Citi keeps AstraZeneca on 'buy' ahead of second-quarter results
Citi keeps AstraZeneca on 'buy' ahead of second-quarter results
Citi keeps AstraZeneca on 'buy' ahead of second-quarter results
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.